D. A. Pizzi

发表

GSK 163090 ) , a Potent , Selective , and Orally Active 5-HT 1 A / B / D Receptor Antagonist

S. Bromidge, S. Ward, A. Jaxa-Chamiec, 2010 .

Discovery and biological characterization of (2R,4S)-1'-acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4'-bipiperidine-1-carboxamide as a new potent and selective neurokinin 1 (NK1) receptor antagonist clinical candidate.

S. Melotto, M. Corsi, D. Montanari, 2011, Journal of medicinal chemistry.

Benzoazepine derivative as potent antagonists of the glycine binding site associated to the NMDA receptor.

S. Provera, D. Donati, F. Micheli, 2003, Farmaco.

Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist.

S. Melotto, M. Corsi, D. Montanari, 2009, Journal of medicinal chemistry.

Discovery and structure-activity relationship of a novel spirocarbamate series of NPY Y5 antagonists.

M. Tessari, L. Caberlotto, G. Merlo, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship of N-(3-azabicyclo[3.1.0]hex-6-ylmethyl)-5-(2-pyridinyl)-1,3-thiazol-2-amines derivatives as NPY Y5 antagonists.

L. Caberlotto, R. Di Fabio, C. Seri, 2010, Bioorganic & medicinal chemistry letters.

Highly Diastereoselective Synthesis of 4-N-Methylformamidino Trinem (GV129606), a Potent Antibacterial Agent

D. Donati, L. Rossi, T. Rossi, 2000 .

Synthesis and antibacterial, activity of 4-ureido trinems

S. Biondi, D. A. Pizzi, D. Andreotti, 1996 .

Synthesis and Antibacterial Activity of 4-Ureido Trinems.

S. Biondi, D. A. Pizzi, D. Andreotti, 1997 .

Novel carbazole derivatives as NPY Y1 antagonists.

F. Pavone, L. Stasi, D. Donati, 2007, Bioorganic & medicinal chemistry letters.

Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors.

L. Mangiarini, E. Greco, R. Di Fabio, 2011, Bioorganic & medicinal chemistry letters.

Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist.

S. Bromidge, S. Ward, A. Jaxa-Chamiec, 2010, Journal of medicinal chemistry.